Trials / Completed
CompletedNCT00926705
Dexmedetomidine Infusion in Hypospadias Surgery
An Intraoperative Infusion of Dexmedetomidine Reduces the Opioid Requirements for Pediatric Patients Undergoing Hypospadias Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University of Jordan · Academic / Other
- Sex
- Male
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that giving Dexmedetomidine in combination with Fentanyl for pediatric patients undergoing hypospadias surgery, will reduce the fentanyl requirement for intraoperative and postoperative analgesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine and Fentanyl | Dexmedetomidine in a dose of 1 ug/kg initial dose then continuous infusion of 0.7 ug/kg/hr . Combined with Fentanyl at a dose of 2 ug/kg initially plus boluses of fentanyl to keep the patient hemodynamically stable. |
| DRUG | Fentanyl | This group received Fentanyl at a dose of 2 ug/kg initially, followed by boluses to keep the patient hemodynamically stable. |
Timeline
- Start date
- 2008-06-01
- Completion
- 2009-01-01
- First posted
- 2009-06-23
- Last updated
- 2009-06-23
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT00926705. Inclusion in this directory is not an endorsement.